Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 16, 2022

DrugPatentWatch Database Preview

Drug Sales Trends for GEMFIBROZIL

Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for GEMFIBROZIL (2019)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$8,858,186
INSIDE ANOTHER STORE	$15,497,701
[disabled in preview]	$31,447,340
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	192,319
INSIDE ANOTHER STORE	737,302
[disabled in preview]	1,438,050
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$10,048,850
MEDICARE	$16,934,373
[disabled in preview]	$28,820,004
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for GEMFIBROZIL

Drug Units Sold Trends for GEMFIBROZIL

Annual Sales Revenues and Units Sold for GEMFIBROZIL

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Sign up for a Free Trial
Drug Name	Revenues (USD)	Units	Year
GEMFIBROZIL	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial	2019
GEMFIBROZIL	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial	2018
GEMFIBROZIL	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial	2017
GEMFIBROZIL	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial	2016
GEMFIBROZIL	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial	2015
GEMFIBROZIL	⤷ Sign up for a Free Trial	⤷ Sign up for a Free Trial	2014
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Johnson and Johnson

Baxter

Medtronic

Dow

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.